Welcome to our dedicated page for TruBridge SEC filings (Ticker: TBRG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Healthcare IT revenue streams can be notoriously opaque. TruBridge’s mix of recurring revenue cycle management fees, electronic health-record licensing, and patient-engagement services means its SEC filings are packed with deferred-revenue tables, segment footnotes, and complex HIPAA-related risk factors. Investors looking for the real driver behind TruBridge’s margin profile—or clues about new hospital-system contracts—must wade through hundreds of pages. This page puts TruBridge SEC filings explained simply at your fingertips.
You’ll find every document, from the TruBridge annual report 10-K simplified to each TruBridge quarterly earnings report 10-Q filing, updated in real time from EDGAR. Our AI-powered summaries extract RCM metrics, spotlight HIPAA disclosures, and translate accounting jargon into plain language. Need to track management moves? Get TruBridge insider trading Form 4 transactions and TruBridge Form 4 insider transactions real-time the moment they post. Handling breaking news? We have every TruBridge 8-K material events explained within minutes, alongside auditor letters, registration statements, and more.
Use the insights, not just the data. Compare segment revenue trends, monitor TruBridge executive stock transactions Form 4 before material announcements, or review the TruBridge proxy statement executive compensation without endless scrolling. Each filing opens with concise AI highlights, interactive charts, and exportable tables, saving hours of manual work. Whether you need TruBridge earnings report filing analysis or guidance on understanding TruBridge SEC documents with AI, our platform delivers clarity, speed, and confidence.
TruBridge, Inc. (TBRG)$20.42 on 11/17/2025, 3,639 shares at
TruBridge, Inc. (TBRG) reported insider share purchases by group filers including L6 Holdings Inc. and Pinetree Capital Ltd. Acting through Pinetree Investment Partnership, they bought 20,707 common shares on 11/17/2025 at a weighted average price of $20.42, 3,639 shares on 11/18/2025 at $20.84, and 8,501 shares on 11/19/2025 at $20.70.
After these purchases, one indirect holding line shows 850,000 TruBridge common shares attributed to Pinetree Investment Partnership, while another line shows 1,995,000 shares held indirectly by L6 Holdings Inc. The reporting persons state that prices are weighted averages over multiple trades within the disclosed ranges and that they may be deemed part of a group owning over 10% of TruBridge’s outstanding securities.
TruBridge, Inc. (TBRG) reported insider buying by its Chief Business Officer, who filed a Form 4 as a single reporting person. The officer purchased common stock in multiple open-market transactions on November 11, 12, 13, 14 and 17, 2025.
The reported weighted average purchase prices were $19.39, $19.95, $20.16, $20.15 and $20.46 per share, each based on multiple trades within stated intraday price ranges. Following these transactions, the officer directly beneficially owned 57,492 shares of TruBridge common stock.
TruBridge, Inc. reported Q3 2025 results, showing steady revenue and a swing to profitability. Total revenue was $86,106 thousand versus $84,700 thousand a year ago, with segment revenue of $54,501 thousand from Financial Health and $31,605 thousand from Patient Care. Operating income rose to $4,068 thousand from $2,814 thousand. Net income was $5,602 thousand compared with a net loss of $9,148 thousand in Q3 2024, or $0.37 per diluted share.
For the nine months, revenue reached $259,043 thousand versus $254,416 thousand, and net income was $8,641 thousand versus a net loss of $15,390 thousand. Interest expense declined year over year, and the company recorded an income tax benefit influenced by the July 2025 OBBBA legislation allowing deductibility of domestic R&D. Cash from operations was $28,107 thousand year-to-date, ending cash was $19,920 thousand, and total debt obligations were $165,166 thousand, with long‑term debt of $161,363 thousand. Deferred revenue ended at $8,197 thousand. As of November 4, 2025, shares outstanding were 15,008,986.
TruBridge, Inc. (TBRG) reported an insider equity award on Form 4. On 10/15/2025, the company’s Chief Business Officer received a grant of 7,492 shares of restricted common stock at a stated price of $0.
The award vests in three equal annual installments, with the first tranche vesting on the first anniversary of the grant date. Following this transaction, the reporting person beneficially owned 7,492 shares, held directly. The filing notes the transaction is exempt under Rule 16b-3(d).
Nellore-affiliated holders disclosed a combined
TruBridge, Inc. (TBRG) reports an initial Form 3 for Michael Daughton, identified as Chief Business Officer and director. The filing states that no securities are beneficially owned by the reporting person as of the event date
Amendment No. 2 to a Schedule 13D for TruBridge, Inc. discloses that reporting persons Gran Fondo Capital B.V. and Rorema Beheer B.V. together beneficially own 950,158 shares, representing 6.3% of TruBridge's outstanding common stock based on 15,011,642 shares outstanding as of August 5, 2025. The filing states the shares were acquired for an aggregate purchase price of approximately $9,066,951, excluding commissions, using the reporting persons' working capital. This amendment is filed solely to include Schedule A, which was inadvertently omitted from Amendment No. 1; Schedule A contains transactions in the past 60 days. The issuer's principal executive office is listed in Mobile, Alabama.